1. Home
  2. CDIO vs MTEX Comparison

CDIO vs MTEX Comparison

Compare CDIO & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • MTEX
  • Stock Information
  • Founded
  • CDIO 2017
  • MTEX 1993
  • Country
  • CDIO United States
  • MTEX United States
  • Employees
  • CDIO N/A
  • MTEX N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • CDIO Health Care
  • MTEX Health Care
  • Exchange
  • CDIO Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • CDIO 20.2M
  • MTEX 21.2M
  • IPO Year
  • CDIO N/A
  • MTEX 1999
  • Fundamental
  • Price
  • CDIO $0.50
  • MTEX $11.24
  • Analyst Decision
  • CDIO Buy
  • MTEX
  • Analyst Count
  • CDIO 1
  • MTEX 0
  • Target Price
  • CDIO $2.00
  • MTEX N/A
  • AVG Volume (30 Days)
  • CDIO 2.5M
  • MTEX 6.5K
  • Earning Date
  • CDIO 03-31-2025
  • MTEX 03-27-2025
  • Dividend Yield
  • CDIO N/A
  • MTEX N/A
  • EPS Growth
  • CDIO N/A
  • MTEX N/A
  • EPS
  • CDIO N/A
  • MTEX N/A
  • Revenue
  • CDIO $35,688.00
  • MTEX $121,552,000.00
  • Revenue This Year
  • CDIO $228.74
  • MTEX N/A
  • Revenue Next Year
  • CDIO $854.55
  • MTEX N/A
  • P/E Ratio
  • CDIO N/A
  • MTEX N/A
  • Revenue Growth
  • CDIO 180.90
  • MTEX N/A
  • 52 Week Low
  • CDIO $0.19
  • MTEX $6.75
  • 52 Week High
  • CDIO $1.86
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 45.05
  • MTEX 46.46
  • Support Level
  • CDIO $0.47
  • MTEX $10.50
  • Resistance Level
  • CDIO $0.69
  • MTEX $11.95
  • Average True Range (ATR)
  • CDIO 0.08
  • MTEX 0.66
  • MACD
  • CDIO 0.01
  • MTEX 0.00
  • Stochastic Oscillator
  • CDIO 33.88
  • MTEX 26.91

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: